BOSTON (AP) _ Ziopharm Oncology Inc. (ZIOP) on Wednesday reported a loss of $13.4 million in its first quarter.
The Boston-based company said it had a loss of 8 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.
In the final minutes of trading on Wednesday, the company's shares hit $4.41. A year ago, they were trading at $4.59.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZIOP at https://www.zacks.com/ap/ZIOP